. /.  WORLD TRADE  
ORGANIZATION   
G/SPS/N/EEC/393/Add.1 
22 September 2011  
 (11-4579) 
Committee on Sanitary and Phytosanitary Measures Original:   English 
  
 
NOTIFICATION 
 
Addendum 
  
The following communication, received on 21 Se ptember 2011, is being circulated at the 
request of the Delegation of the European Union. 
 
_______________ 
  
Maximum residue levels for abamectin, acetamip rid, cyprodinil, difenoconazole, dimethomorph, 
fenhexamid, proquinazid, prothioconazole, pyraclos trobin, spirotetramat, thiacloprid, thiamethoxam 
and trifloxystrobin, and in or on certain products  
 The proposal notified in G/SPS/N/EEC/393 (4  February 2011) has been adopted as 
"Commission Regulation (EU) No 508/2011 of 24 May 2011 amending Annexes II and III to 
Regulation (EC) No 396/2005 of the European Par liament and of the Council as regards maximum 
residue levels for abamectin, acetamiprid, cyprod inil, difenoconazole, dime thomorph, fenhexamid, 
proquinazid, prothioconazole, pyraclostrobin, sp irotetramat, thiacloprid, thiamethoxam and 
trifloxystrobin in or on certain products" (OJ L 137. 25 May 2011, pp. 3-52).   
http://eur-lex.europa.eu/LexUriServ/LexUr iServ.do?uri=OJ:L:2011:137:0003:0052:EN:PDF  
http://eur-lex.europa.eu/LexUriServ/LexUr iServ.do?uri=OJ:L:2011:137:0003:0052:FR:PDF  
http://eur-lex.europa.eu/LexUriServ/LexUr iServ.do?uri=OJ:L:2011: 137:0003:0052:ES:PDF  
or 
http://members.wto.org/crnattach ments/2011/sps/EEC/11_3047_00_e.pdf  
http://members.wto.org/crnattachments/2011/sps/EEC/11_3047_00_f.pdf  
http://members.wto.org/crnattach ments/2011/sps/EEC/11_3047_00_s.pdf  
This addendum concerns a: 
[ ] Modification of final date for comments 
[X] Notification of adoption, publication or entry into force of regulation 
[ ] Modification of content and/or scope of previously notified draft regulation 
[ ] Withdrawal of proposed regulation 
[ ] Change in proposed date of adoption, publication or date of entry into force 
[ ] Other:    G/SPS/N/EEC/393/Add.1 
Page 2  
 
  Comment period:  (If the addendum extends the scope of th e previously notified measure in terms 
of products and/or potentially affected Members, a new deadline for receipt of comments should be 
provided, normally of at least 60 calendar days.  Under other circumstances, such as extension of 
originally announced final date for comments, th e comment period provided in the addendum may 
vary.)  
[ ] Sixty days from the date of circulation of the addendum to the notification and/or 
(dd/mm/yy) :  Not applicable 
Agency or authority designated to handle comments:  [X] National Notification Authority, 
[X] National Enquiry Point.  Address, fax number and e-mail address (if available) of other 
body: 
European Commission 
DG Health and Consumers, Unit G6 - Multilateral International Relations 
Rue Froissart 101 B-1049 Brussels Tel.:  +(322) 29 68185/59922 
Fax:  +(322) 29 98090 
E-mail:  sps@ec.europa.eu  
Text available from:  [X] National Notification Au thority, [X] National Enquiry Point.  Address, 
fax number and e-mail address (if available) of other body: 
European Commission 
DG Health and Consumers, Unit G6 - Multilateral International Relations 
Rue Froissart 101 
B-1049 Brussels Tel.:  +(322) 29 68185/59922 Fax:  +(322) 29 98090 E-mail:  sps@ec.europa.eu  
 
__________